CeriBell, Inc. (NASDAQ:CBLL - Get Free Report) VP David Foehr sold 859 shares of CeriBell stock in a transaction dated Monday, August 24th. The shares were sold at an average price of $23.95, for a total transaction of $20,573.05. Following the sale, the vice president owned 35,899 shares of the company's stock, valued at $859,781.05. The trade was a 2.34% decrease in their position. The sale was disclosed in a filing with the Securities & Exchange Commission, which can be accessed through the SEC website. The sale was made to cover tax withholding obligations related to the vesting of equity awards.
David Foehr also recently made the following trade(s):
- On Friday, August 21st, David Foehr sold 993 shares of CeriBell stock. The stock was sold at an average price of $24.02, for a total value of $23,851.86.
CeriBell Price Performance
CBLL opened at $23.95 on Wednesday. The company has a current ratio of 9.18, a quick ratio of 8.79 and a debt-to-equity ratio of 0.16. The business's fifty day simple moving average is $19.77 and its 200-day simple moving average is $19.27. The company has a market capitalization of $919.20 million, a price-to-earnings ratio of -13.61 and a beta of 0.81. CeriBell, Inc. has a 12-month low of $10.85 and a 12-month high of $25.33.
CeriBell (NASDAQ:CBLL - Get Free Report) last released its quarterly earnings data on Monday, August 10th. The company reported ($0.51) earnings per share for the quarter, missing analysts' consensus estimates of ($0.47) by ($0.04). CeriBell had a negative return on equity of 44.85% and a negative net margin of 64.73%.The business had revenue of $28.10 million during the quarter, compared to analysts' expectations of $27.28 million. On average, equities research analysts anticipate that CeriBell, Inc. will post -1.96 earnings per share for the current fiscal year.
Institutional Inflows and Outflows
A number of hedge funds have recently modified their holdings of the company. Caitong International Asset Management Co. Ltd lifted its stake in CeriBell by 3,971.0% during the 4th quarter. Caitong International Asset Management Co. Ltd now owns 1,262 shares of the company's stock valued at $28,000 after acquiring an additional 1,231 shares during the period. Strs Ohio acquired a new position in CeriBell during the first quarter valued at $27,000. CWM LLC boosted its holdings in CeriBell by 1,178.5% in the fourth quarter. CWM LLC now owns 1,841 shares of the company's stock valued at $40,000 after purchasing an additional 1,697 shares during the last quarter. Tower Research Capital LLC TRC grew its position in CeriBell by 353.8% during the 2nd quarter. Tower Research Capital LLC TRC now owns 2,310 shares of the company's stock worth $43,000 after purchasing an additional 1,801 shares during the period. Finally, Legal & General Group Plc acquired a new position in shares of CeriBell in the 2nd quarter valued at about $53,000.
Key Headlines Impacting CeriBell
Here are the key news stories impacting CeriBell this week:
- Neutral Sentiment: CEO Xingjuan Chao, CFO Scott Blumberg, CTO Raymond Woo, CRO Joseph S. Manni and VP David Foehr collectively sold approximately 12,781 shares for about $307,000. Each filing stated that the shares were sold to cover tax-withholding obligations after equity awards vested, and the executives retained substantial remaining holdings. SEC insider transaction filings
- Neutral Sentiment: Reported short interest was zero shares as of August 25, unchanged from zero shares on August 10, with a zero-day days-to-cover ratio. Because the figures include a “NaN” change and may reflect incomplete or anomalous reporting, they provide little actionable information about bearish positioning.
- Negative Sentiment: The cluster of sales by multiple senior executives could create a modest overhang for CBLL, particularly with the stock trading close to its 12-month peak. However, the relatively small size of the transactions and their stated tax-related purpose lessen the signal that management is broadly reducing exposure.
Analyst Upgrades and Downgrades
A number of brokerages recently commented on CBLL. BTIG Research boosted their price objective on shares of CeriBell from $28.00 to $30.00 and gave the stock a "buy" rating in a research note on Tuesday, August 18th. Weiss Ratings upgraded CeriBell from a "sell (e+)" rating to a "sell (d-)" rating in a research note on Thursday, August 13th. Canaccord Genuity Group increased their price objective on shares of CeriBell from $25.00 to $26.00 and gave the company a "buy" rating in a research report on Tuesday, August 11th. Finally, Barclays raised shares of CeriBell to a "neutral" rating in a research report on Tuesday, August 18th. One investment analyst has rated the stock with a Strong Buy rating, four have assigned a Buy rating, one has given a Hold rating and one has assigned a Sell rating to the company's stock. According to data from MarketBeat.com, CeriBell has an average rating of "Moderate Buy" and a consensus target price of $22.40.
Read Our Latest Analysis on CeriBell
CeriBell Company Profile
(
Get Free Report)
CeriBell Corp (NASDAQ: CBLL) is a healthcare technology company specializing in the design, manufacture and sale of automated newborn hearing screening devices. The company offers a suite of medical diagnostic tools based on otoacoustic emissions (OAE) and auditory brainstem response (ABR) technologies, enabling early detection of auditory impairments in infants. CeriBell's solutions are used in hospitals, birthing centers and audiology clinics to support universal newborn hearing screening programs aimed at improving language development outcomes through prompt intervention.
The company's product portfolio includes handheld and desktop screening units, proprietary software for data management, and accessories designed to streamline testing workflows.
Featured Stories
This instant news alert was generated by narrative science technology and financial data from InsiderTrades.com in order to provide readers with the fastest and most accurate reporting. Please send any questions or comments about this story to [email protected].
